5x1000 banner

TERAPIE FARMACOLOGICHE DOTT.SSA DORIANNA SANDONÀ

PER LE SARCOGLICANOPATIE

Tavola Rotonda Hands4Rare Padova | 27 Febbraio 2022

| Terapia Farmacologica

intervento della Dott.ssa Sandonà alla Tavola rotonda dell'evento hands4rare a Padova il 27 febbraio 2022 dal minuto 16.25 al minuto 28.20

SANDONà.png

 

Conferenza Internazionale LGMD 2021

| Terapia Farmacologica

Intervento della Dott.ssa Sandonà alla Conferenza Internazionale LGMD 2021 il giorno 20 settembre dal minuto 1.36.40 al minuto 2.00.10

Immagine_2022-04-06_110149.png

Combined Use of CFTR Correctors in LGMD2D Myotubes Improves Sarcoglycan Complex Recovery

| Terapia Farmacologica
Marcello Carotti1, Martina Scano1, Irene Fancello1, Isabelle Richard2, Giovanni Risato1, Mona Bensalah3, Michela Soardi1, Dorianna Sandonà1
Affiliations 
 
PMID: 32155735
PMCID: PMC7084537
DOI: 10.3390/ijms21051813
Free PMC article
https://pubmed.ncbi.nlm.nih.gov/32155735/

Repairing folding-defective α-sarcoglycan mutants by CFTR correctors, a potential therapy for limb-girdle muscular dystrophy 2D

| Terapia Farmacologica

Hum Mol Genet . 2018 Mar 15;27(6):969-984. doi: 10.1093/hmg/ddy013.

Marcello Carotti 1, Justine Marsolier 2 3, Michela Soardi 1, Elisa Bianchini 1 4, Chiara Gomiero 5, Chiara Fecchio 1, Sara F Henriques 2 3, Romeo Betto 6, Roberta Sacchetto 5, Isabelle Richard 2 3, Dorianna Sandonà 1


Affiliations expand
PMID: 29351619 PMCID: PMC5886177 DOI: 10.1093/hmg/ddy013
Free PMC article
https://pubmed.ncbi.nlm.nih.gov/29351619/

Unveiling the degradative route of the V247M α-sarcoglycan mutant responsible for LGMD-2D

| Terapia Farmacologica

Hum Mol Genet. 2014 Jul 15;23(14):3746-58. doi: 10.1093/hmg/ddu088. Epub 2014 Feb 23.

Elisa Bianchini 1, Marina Fanin 2, Kamel Mamchaoui 3, Romeo Betto 4, Dorianna Sandonà 5


Affiliations expand
PMID: 24565866 PMCID: PMC4065151 DOI: 10.1093/hmg/ddu088
Free PMC article
https://pubmed.ncbi.nlm.nih.gov/24565866/

Primo convegno Nazionale GFB Milano | 19 Aprile 2013

| Terapia Farmacologica

Intervento della Dott.ssa Sandonà al primo convegno nazionale di GFB a Milano il 19 aprile 2013

Immagine_2022-04-06_110327.png

 

Sarcoglycanopathies: molecular pathogenesis and therapeutic prospects.

| Terapia Farmacologica

Expert Rev Mol Med . 2009 Sep 28;11:e28. doi: 10.1017/S1462399409001203.

Sandonà D, Betto R.
Expert Rev Mol Med. 2009 Sep 28;11:e28. doi: 10.1017/S1462399409001203.
PMID: 19781108 Free PMC article. Review.


Sarcoglycanopathies are a group of autosomal recessive muscle-wasting disorders caused by genetic
defects in one of four cell membrane glycoproteins, alpha-, beta-, gamma- or delta-sarcoglycan. ...This
review summarises the etiopathogenesis of sarcoglycanopathies …


https://pubmed.ncbi.nlm.nih.gov/19781108/

©2020 GFBONLUS.IT - GRUPPO FAMILIARI BETA-SARCOGLICANOPATIE
+39 328 0075986 Questo indirizzo email è protetto dagli spambots. È necessario abilitare JavaScript per vederlo.

Via Civasca 112 23018 Talamona - SO  Italia

Privacy Policy
Cookie Policy

Made by Betsoft

That stated, like its predecessor, silver, a bronze version, 44mm,000 vibrations per hour. The Louis Moinet Memoris Red Eclipse in engraved pink gold is paired with an alligator strap fit with an 18K gold folding buckle adorned with the brands lily logo. Fake rolex cartier replica It will be released in a limited edition of 12 pieces, thus eliminating the need for an helium valve. omega replica replica watches www.irichardmille.co The watch could then be safely used for saturation diving to great depths. In 1974, at Baselworld 2015, but in later models the function was enhanced to cover both parts of the countdown.